MedPath
HSA Approval

PEMEX POWDER FOR SOLUTION FOR INJECTION 100MG/VIAL

SIN15622P

PEMEX POWDER FOR SOLUTION FOR INJECTION 100MG/VIAL

PEMEX POWDER FOR SOLUTION FOR INJECTION 100MG/VIAL

February 8, 2019

DCH AURIGA SINGAPORE

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDCH AURIGA SINGAPORE
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS

Medical Information

L01BA04

pemetrexed

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD.

Active Ingredients

PEMETREXED DISODIUM HEMIPENTAHYDRATE 120.8mg eqv PEMETREXED

100mg

Pemetrexed

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PEMEX POWDER FOR SOLUTION FOR INJECTION 100MG/VIAL - HSA Approval | MedPath